-
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunity
van Delft, M. A. M., Aleyd, E., Mast, R. V. D., de Jong, N., Boon, L., Simons, P. J. & van Egmond, M., 2023, In: Frontiers in immunology. 14, p. 1118539 1118539.Research output: Contribution to journal › Article › Academic › peer-review
-
Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype Switching
Bos, A. V., van Gool, M. M. J., Breedveld, A. C., van der Mast, R., Marsman, C., Bouma, G., van de Wiel, M. A., van Ham, S. M., Mebius, R. E. & van Egmond, M., 1 Oct 2022, In: International journal of molecular sciences. 23, 19, 18 p., 11132.Research output: Contribution to journal › Article › Academic › peer-review
-
Nk cell-dependent antibody-mediated immunotherapy is improved in vitro and in vivo when combined with agonists for toll-like receptor 2 in head and neck cancer models
Gruijs, M., Ganzevles, S. H., Stigter-Van Walsum, M., van der Mast, R., van Ostaijen-Ten Dam, M. M., Tuk, C. W., Schilham, M. W., Leemans, C. R., Brakenhoff, R. H., van Egmond, M., van de Ven, R. & Bakema, J. E., 1 Oct 2021, In: International journal of molecular sciences. 22, 20, 11057.Research output: Contribution to journal › Article › Academic › peer-review
- All publications